COVID-19 vaccine effectiveness among immunocompromised populations: a targeted literature review of real-world studies
Author:
Affiliation:
1. Pfizer Inc., New York, NY, USA
2. Novosys Health, Green Brook, NJ, USA
3. HealthEcon Consulting Inc., Ancaster, ON, Canada
4. Pfizer Inc., Collegeville, PA, USA
Funder
Pfizer, Inc
Publisher
Informa UK Limited
Subject
Drug Discovery,Pharmacology,Molecular Medicine,Immunology
Link
https://www.tandfonline.com/doi/pdf/10.1080/14760584.2022.2035222
Reference58 articles.
1. OurWorldinData.org [Internet]. Statistics and research: coronavirus (COVID-19) vaccinations. London (England): Oxford; [cited 2021 Sep 30]. Available from: https://ourworldindata.org/covid-vaccinations
2. Cdc.gov [Internet]. Atlanta (GA): centers for disease control and prevention. Science brief: COVID-19 vaccines and vaccination. Updated 2021 Sep 15. cited 2021 Oct 19]. Available from: https://www.cdc.gov/coronavirus/2019-ncov/science/science-briefs/fully-vaccinated-people.html.
3. Effectiveness of COVID‐19 vaccines: findings from real world studies
4. Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine
5. Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine
Cited by 45 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Substantial health and economic burden of COVID-19 during the year after acute illness among US adults at high risk of severe COVID-19;BMC Medicine;2024-02-01
2. IgG antibody response to SARS-CoV-2 infection and its influencing factors in lymphoma patients;BMC Immunology;2024-01-13
3. Responses to Common Misconceptions Relating to COVID-19 Variant-Adapted mRNA Vaccines;Vaccines;2024-01-06
4. Safety and Efficacy of Inactivated SARS-CoV-2 Vaccine in Patients with Rheumatic Diseases and Serum Antibody Changes Post-Omicron Variant Infection;Rheumatology and Therapy;2024-01-04
5. Targeting epidermal growth factor receptor signalling pathway: A promising therapeutic option for COVID‐19;Reviews in Medical Virology;2023-12-21
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3